Why nursing home COVID-19 infections are rising again


Dr. Ashish Jha, the dean of the Brown University School of Public Health, noted Sunday that nursing home COVID-19 infections are rising again in the United States. While that may be surprising given the high vaccination rate among long-term care facility residents, Jha (who has been vocal about the fact that the shots are doing their jobs) explained why the situation is more complex than that in a Twitter thread on Sunday.
For starters, he says, the vaccination rate among residents is high, but not complete — 19 percent have not been inoculated. More importantly, though, 42 percent of nursing home workers are unvaccinated, leaving them more vulnerable to infection and making them more likely to spread the virus during the Delta variant-fueled surge across the U.S. "When community transmission rises, more COVID shows up in nursing homes," Jha tweeted.
At the same time, breakthrough infections, while a small risk for the wider population (both in terms of occurrence and severity of illness), can be more serious among elderly and frail individuals, especially because they received their vaccines much earlier in the process than younger folks. Jha and others noted on Sunday that data from Israel suggest that immunity may begin to wane several months out.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
There are two solutions, Jha said. The first is too ensure all nursing home workers are vaccinated, and the second is for the Food and Drug Administration to "rapidly determine" if a booster shot is necessary for elderly and immunocompromised people. "I suspect it is," he writes. Read Jha's thread on Twitter.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Shohei Ohtani is caught in a financial controversy — again
In the Spotlight The controversy concerns Ohtani and his agent, Nez Balelo
-
A descent into academic Hell, a ferocious feminist fable and the adult debut of a beloved children's author
The Week Recommends August books include R.F. Kuang's 'Katabasis,' Xenobe Purvis' 'The Hounding' and Louis Sachar's 'The Magician of Tiger Castle'
-
What is an upside-down car loan and how do you get out of it?
the explainer This happens when the outstanding balance on a car loan exceeds the vehicle's worth
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts